mireca.eu valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title Mireca
Description Protecting eyesight with a small molecule in a broad band of mutations Home About Science News Contact Protecting eyesight with a small molecule in a broa
Keywords N/A
Server Information
WebSite mireca faviconmireca.eu
Host IP 198.185.159.144
Location United States
Related Websites
Site Rank
More to Explore
mireca.eu Valuation
US$2,123
Last updated: 2023-05-07 08:19:27

mireca.eu has Semrush global rank of 0. mireca.eu has an estimated worth of US$ 2,123, based on its estimated Ads revenue. mireca.eu receives approximately 244 unique visitors each day. Its web server is located in United States, with IP address 198.185.159.144. According to SiteAdvisor, mireca.eu is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$2,123
Daily Ads Revenue US$1
Monthly Ads Revenue US$58
Yearly Ads Revenue US$705
Daily Unique Visitors 16
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
mireca.eu. A 900 IP: 198.185.159.144
mireca.eu. A 900 IP: 198.185.159.145
mireca.eu. NS 900 NS Record: ns3.directictserver.info.
mireca.eu. NS 900 NS Record: ns2.directictserver.nl.
mireca.eu. NS 900 NS Record: ns1.directictserver.nl.
mireca.eu. MX 900 MX Record: 10 mireca-eu.mail.protection.outlook.com.
mireca.eu. TXT 900 TXT Record: v=spf1 include:spf.protection.outlook.com include:_spf.directictserver.nl ~all
mireca.eu. TXT 900 TXT Record: MS=ms92201441
HtmlToTextCheckTime:2023-05-07 08:19:27
Protecting eyesight with a small molecule in a broad band of mutations Home About Science News Contact Protecting eyesight with a small molecule in a broad band of mutations Home About Science News Contact MIRECA Corrected cGMP signaling Developing cGMP analogue drug products Mireca Medicines GmbH is an expanding, preclinical stage startup company pioneering the development of cyclic guanosine monophosphate (cGMP) analogues to treat diseases caused by a dysregulation of cGMP signaling, affecting protein kinase G (PKG). In a first selection to deploy its cGMP library for this pathway, Mireca focusses on the inhibition of cGMP signaling for neuroprotection. Positive preclinical data for inherited retinal diseases like Retinitis Pigmentosa and a licensing deal for all eye and ear applications with US Nasdaq listed Graybug Vision, Inc. confirms the drug development potential of this approach. In the light of Graybug’s merger with CalciMedica all assets were returned to Mireca for further
HTTP Headers
HTTP/1.1 301 Moved Permanently
Age: 248949
Date: Sun, 24 Oct 2021 19:08:11 GMT
Location: https://www.mireca.eu/
Server: Squarespace
Set-Cookie: crumb=BfymmlxMgKzJM2Q0NzhkZDdlNGYzZGYwZTRiNTU4MTExYmM5Zjll;Path=/
X-Contextid: FbCS2yMu/e4RnxBgg

HTTP/2 200 
accept-ranges: bytes
age: 453189
content-type: text/html;charset=utf-8
date: Fri, 22 Oct 2021 10:24:12 GMT
etag: W/"d1a15c9862f894c7b3a507b4690eebe9"
expires: Thu, 01 Jan 1970 00:00:00 GMT
server: Squarespace
set-cookie: crumb=BW5cP4r/ZZ0YMjE2NzliZjA5NzMwOGQzOWM1M2Y0ODEyZTA1MWZh;Path=/
strict-transport-security: max-age=43200
vary: Accept-Encoding
x-content-type-options: nosniff
x-contextid: ZbMtzu97/tvMH6BUt
content-length: 10880
mireca.eu Whois Information
Domain: mireca.eu
Script: LATIN
NOT DISCLOSED!
Visit www.eurid.eu for webbased WHOIS.
NOT DISCLOSED!
Visit www.eurid.eu for webbased WHOIS.
Organisation: ISE
Language: en
Email: office@i-s-e.nl
Name: Internet Service Europe BV
Website: www.i-s-e.nl
ns3.directictserver.info
ns2.directictserver.nl
ns1.directictserver.nl
Please visit www.eurid.eu for more info.